MedTrace Logo

Post-op Prednisone and Glucose Monitoring in TKA

NCT07630896 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2026-06-05

No results posted yet for this study

Summary

This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.

Conditions

  • Osteoarthritis
  • Unicompartmental Knee Arthroplasty
  • Total Hip Arthroplasty (THA)

Interventions

DRUG

Prednisone

40 mg daily for 5 days

DEVICE

Continuous Glucose Monitor

Provides real-time glucose readings for up to 14 days

OTHER

InkWell Health Tattoos

Temporary medical-grade tattoos that provide real-time monitoring of knee swelling and range of motion

Sponsors & Collaborators

  • Orthopaedic Scientific Research Foundation

    collaborator UNKNOWN

  • Columbia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-12-31
Completion
2028-03-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07630896 on ClinicalTrials.gov